Merck Strategy Still Murky As Jury Mulls Vioxx Claims
For Merck & Co. to successfully defend itself against more than 13,000 lawsuits over the former blockbuster drug Vioxx, the case deliberated Wednesday by a New Jersey jury seems like a...To view the full article, register now.
Already a subscriber? Click here to view full article